The retardation of myometrial infiltration, reduction of uterine contractility, and alleviation of generalized hyperalgesia in mice with induced adenomyosis by levo-tetrahydropalmatine (l-THP) and andrographolide

other OA: closed public-domain-us ⤵ 1 in-corpus citation
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-12

Levo-tetrahydropalmatine and andrographolide treatments suppressed myometrial infiltration, improved hyperalgesia, and reduced uterine contractility in a mouse model of adenomyosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-12 · read from full text

The paper investigated whether levo-tetrahydropalmatine (l-THP), andrographolide (an NF-κB inhibitor), or valproic acid (VPA)—alone or l-THP plus andrographolide—can suppress uterine changes and pain behaviors in a neonatal tamoxifen-induced mouse model of adenomyosis. Using hotplate tests to assess generalized hyperalgesia and measuring depth of myometrial infiltration of ectopic endometrium plus uterine contraction amplitude and irregularity after 3 weeks of treatment, the authors found that adenomyosis induction produced progressive generalized hyperalgesia and elevated, irregular uterine contractions, while each treatment option reduced myometrial infiltration, improved hyperalgesia, and normalized contraction amplitude/regularity. A key limitation is that all animals were killed after treatment with outcomes assessed at one post-treatment time point, without reporting longer-term durability of effects. This paper is centrally about adenomyosis — l-THP and andrographolide (and VPA) are tested for reducing myometrial infiltration, uterine contractility, and generalized hyperalgesia in an induced adenomyosis mouse model.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Adenomyosis is a tough disease to manage nonsurgically. Levo-tetrahydropalmatine (l-THP), a known analgesic, and andrographolide, a nuclear factor kappa B (NF-κB) inhibitor, are both active ingredients extracted from Chinese medicinal herbs. We sought to determine whether treatment of l-THP, andrographolide, and valproic acid (VPA) would suppress the myometrial infiltration, improve pain behavior, and reduce uterine contractility in a mice model of adenomyosis. Adenomyosis was induced in 55 female ICR mice neonatally dosed with tamoxifen, while another 8 (group C) were dosed with solvent only. Starting from 4 weeks after birth, hotplate test was administrated to all mice every 4 weeks. At the 16th week, all mice with induced adenomyosis were randomly divided into 6 groups, each receiving different treatment for 3 weeks: low- or high-dose l-THP, andrographolide, low-dose l-THP and andrographolide jointly, VPA, and untreated. Group C received no treatment. After treatment, the hotplate test was administered and all mice were killed. The depth of myometrial infiltration of ectopic endometrium and uterine contractility were measured and compared across groups. We found that induction of adenomyosis resulted in progressive generalized hyperalgesia, along with elevated amplitude and irregularity of uterine contractions. Treatment with either l-THP, andrographolide, VPA, or l-THP and andrographolide jointly suppressed myometrial infiltration, improved generalized hyperalgesia, and reduced the amplitude and irregularity of uterine contractions. These results suggest that increased uterine contractility, in the form of increased contractile amplitude and irregularity, may contribute to dysmenorrhea in women with adenomyosis. More importantly, l-THP, andrographolide, and VPA all seem to be promising compounds for treating adenomyosis.
Full text 15,015 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Adenomyosis is a tough disease to manage nonsurgically. Levo-tetrahydropalmatine (l-THP), a known analgesic, and andrographolide, a nuclear factor kappa B (NF-κB) inhibitor, are both active ingredients extracted from Chinese medicinal herbs. We sought to determine whether treatment of l-THP, andrographolide, and valproic acid (VPA) would suppress the myometrial infiltration, improve pain behavior, and reduce uterine contractility in a mice model of adenomyosis. Adenomyosis was induced in 55 female ICR mice neonatally dosed with tamoxifen, while another 8 (group C) were dosed with solvent only. Starting from 4 weeks after birth, hotplate test was administrated to all mice every 4 weeks. At the 16th week, all mice with induced adenomyosis were randomly divided into 6 groups, each receiving different treatment for 3 weeks: low- or high-dose l-THP, andrographolide, low-dose l-THP and andrographolide jointly, VPA, and untreated. Group C received no treatment. After treatment, the hotplate test was administered and all mice were killed. The depth of myometrial infiltration of ectopic endometrium and uterine contractility were measured and compared across groups. We found that induction of adenomyosis resulted in progressive generalized hyperalgesia, along with elevated amplitude and irregularity of uterine contractions. Treatment with either l-THP, andrographolide, VPA, or l-THP and andrographolide jointly suppressed myometrial infiltration, improved generalized hyperalgesia, and reduced the amplitude and irregularity of uterine contractions. These results suggest that increased uterine contractility, in the form of increased contractile amplitude and irregularity, may contribute to dysmenorrhea in women with adenomyosis. More importantly, l-THP, andrographolide, and VPA all seem to be promising compounds for treating adenomyosis. Similar content being viewed by others

References

Bergeron C, Amant F, Ferenczy A. Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):511–521 Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):603–616 Matalliotakis IM, Kourtis AI. Panidis DK: Adenomyosis. Obstet Gynecol Clin North Am. 2003;30(1):63–82, viii Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):603–616 Green AR, Styles JA, Parrott EL, et al. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol. 2005;56(4–5):255–263 Parrott E, Butterworth M, Green A, White IN, Greaves P. Adenomyosis-a result of disordered stromal differentiation. Am J Pathol. 2001;159(2):623–630 Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607 Liu X, Guo SW. A pilot study on the off-label use of valproic acid to treat adenomyosis. Fertil Steril. 2008;89(1):246–250 Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106–111 Nie J, Liu XS, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 2010;17(11):995–1005 Liu XS, Yuan L, Guo SW. Vaproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;17(10):904–912 Pickhardt PJ, Kim DH, Menias CO, Gopal DV, Arluk GM, Heise CP. Evaluation of submucosal lesions of the large intestine: part 2. Nonneoplastic causes. Radiographics. 2007;27(6):1693–1703 Leyendecker G, Wildt L, Mall G. The pathophysiology of endometriosis and adenomyosis: tissue injury and repair. Arch Gynecol Obstet. 2009;280(4):529–538 Mehasseb MK, Bell SC, Pringle JH, Habiba MA. Uterine adenomyosis is associated with ultrastructural features of altered contractility in the inner myometrium. Fertil Steril. 2010;93(7):2130–2136 Mechsner S, Grum B, Gericke C, Loddenkemper C, Dudenhausen JW, Ebert AD. Possible roles of oxytocin receptor and vasopressin-1alpha receptor in the pathomechanism of dysperistalsis and dysmenorrhea in patients with adenomyosis uteri. Fertil Steril. 2010;94(7):2541–2546 Nie J, Liu X, Guo SW. Immunoreactivity of oxytocin receptor and transient receptor potential vanilloid type 1 and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol. 2010;202(4):346 e341–348 Hu JY, Jin GZ. Effect of tetrahydropalmatine analogs on Fos expression induced by formalin-pain. Zhongguo Yao Li Xue Bao. 1999;20(3):193–200 Han YF, Hou LH, Zhou YJ, Wu XK. A survey of TCM treatment for endometriosis. J Tradit Chin Med. 2009;29(1):64–70 Chu H, Jin G, Friedman E, Zhen X. Recent development in studies of tetrahydroprotoberberines: mechanism in antinociception and drug addiction. Cell Mol Neurobiol. 2008;28(4):491–499 Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virginal rats (in Chinese). J Clin Rehab Tissue Eng Res. 2007;11(5):4178–4181 Zhao GJ, Ren SL, Wu SG, Yu LS. Effect of L-THP on contraction of blood vessels induced by 5-hydroxytryptamine (in Chinese). Chin J Pharmacol Toxicol. 1988;4(2):342–348 Xing JF, Wang MN, Ma XY, Liang WW, Wang YH. Effects of dl tetrahydropalmation on rabbit platelet aggregation and experimental cerebral thrombosis in rats (in Chinese). Chin Pharmacol Bull. 1997;13(5):258–210 Zhao T, Liu XS, Zhen XC, Guo SW. Levo-tetrahydropalmatine (l-THP) retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci. 2011;18(1):28–45 Xia YF, Ye BQ, Li YD, et al. Andrographolide attenuates inflammation by inhibition of NF-kappa B activation through covalent modification of reduced cysteine 62 of p50. J Immunol. 2004;173(6):4207–4217 Nie J, Lu Y, Liu X, Guo SW. Immunoreactivity of progesterone receptor isoform B, nuclear factor kappaB, and IkappaBalpha in adenomyosis. Fertil Steril. 2009;92(3):886–889 Council NR. Guide for the Care and use of Laboratory Animals. Washington, DC: National Academies Press; 1996. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. FASEB J. 2008;22(3):659–661 Bird CC, McElin TW, Manalo-Estrella P. The elusive adenomyosis of the uterus-revisited. Am J Obstet Gynecol. 1972;112(5):583–593 Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597–652 Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007;Chapter 8:Unit 8 9. Bygdeman M, Eliasson R. Effect of progesterone and oestrone on the motility and reactivity of the pregnant human myometrium in vitro. J Reprod Fertil. 1964;7:47–52 Calixto JB, Yunes RA. Antagonism of kinin-induced contraction of isolated rat uterus by the crude hydroalcoholic extract from Mandevilla illustris. Gen Pharmacol. 1991;22(1):99–101 Hernandez-Magro PM, Villanueva Saenz E, Alvarez-Tostado Fernandez F, Luis Rocha Ramirez J, Valdes Ovalle M. Endoanal sonography in the assessment of perianal endometriosis with external anal sphincter involvement. J Clin Ultrasound. 2002;30(4):245–248 Percival DB, Walden AT. Wavelet Methods for Time Series Analysis. Cambridge, UK: University of Cambridge Press; 2000:594. Bruce A, Gao H-Y. Applied Wavelet Analysis With S-PLUS. New York, NY: Springer-Verlag; 1996. Daubechies I. Ten Lectures on Wavelets. CBMS-NSF Regional Conference Series in Applied Mathematics. New York, NY: SIAM; 1992. Kooperberg C, Bose S, Stone CJ. Polychotomous regression. J Am Statist Assoc. 1997;92(3):117–127 Team RDC. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing; 2009. Cui L, Wu T. [L-Tetrahydropalmatine enhances inhibition of cellular proliferation by Vincristine Sulfate in human leukemia cell lines] (in Chinese). Chin Pharmacol Bull. 1995;11(5):348 Lagadec C, Meignan S, Adriaenssens E, et al. TrkA overexpression enhances growth and metastasis of breast cancer cells. Oncogene. 2009;28(18):1960–1970 Kawanami Y, Morimoto Y, Kim H, et al. Calcitonin gene-related peptide stimulates proliferation of alveolar epithelial cells. Respir Res. 2009;10:8 Ribatti D, Nico B, Perra MT, et al. Correlation between NGF/ TrkA and microvascular density in human pterygium. Int J Exp Pathol. 2009;90(6):615–620 Okajima K, Harada N. Promotion of insulin-like growth factor-I production by sensory neuron stimulation; molecular mechanism(s) and therapeutic implications. Curr Med Chem. 2008;15(29):3095–3112 Xu JD, Wang W, Yang HX, Li ZQ, Ma LY, Hou XL. [Inhibitive effect of tetrahydropalmatine on contractile activity of uterine smooth muscle strips in virgin rats.] (In Chinese). J Clin Rehab Tis Eng Res. 2007;11(5):4178–4181 Huang K, Dai GZ, Li XH, et al. Blocking L-calcium current by l-tetrahydropalmatine in single ventricular myocyte of guinea pigs. Zhongguo Yao Li Xue Bao. 1999;20(10):907–911 Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926 Kumar A, Takada Y, Boriek AM, Aggarwal BB. Nuclear factor-kappaB: its role in health and disease. J Mol Med. 2004;82(7):434–448 Zhang N, Oppenheim JJ. Crosstalk between chemokines and neuronal receptors bridges immune and nervous systems. J Leukoc Biol. 2005;78(6):1210–1214 Kunz G, Noe M, Herbertz M, Leyendecker G. Uterine peristalsis during the follicular phase of the menstrual cycle: effects of oestrogen, antioestrogen and oxytocin. Hum Reprod Update. 1998;4(5):647–654 Wilson T, Liggins GC, Whittaker DJ. Oxytocin stimulates the release of arachidonic acid and prostaglandin F2 alpha from human decidual cells. Prostaglandins. 1988;35(5):771–780 Burns PD, Mendes JO Jr., Yemm RS, et al. Cellular mechanisms by which oxytocin mediates ovine endometrial prostaglandin F2alpha synthesis: role of G(i) proteins and mitogen-activated protein kinases. Biol Reprod. 2001;65(4):1150–1155 Sales KJ, Jabbour HN. Cyclooxygenase enzymes and prostaglandins in pathology of the endometrium. Reproduction. 2003;126(5):559–567 Sales KJ, Grant V, Jabbour HN. Prostaglandin E2 and F2alpha activate the FP receptor and up-regulate cyclooxygenase-2 expression via the cyclic AMP response element. Mol Cell Endocrinol. 2008;285(1–2):51–61 Kitawaki J. Adenomyosis: the pathophysiology of an oestrogen-dependent disease. Best Pract Res Clin Obstet Gynaecol. 2006;20(4):493–502 Fleming JG, Spencer TE, Safe SH, Bazer FW. Estrogen regulates transcription of the ovine oxytocin receptor gene through GC-rich SP1 promoter elements. Endocrinology. 2006;147(2):899–911 Terzidou V, Lee Y, Lindstrom T, Johnson M, Thornton S, Bennett PR. Regulation of the human oxytocin receptor by nuclear factor-kappaB and CCAAT/enhancer-binding protein-beta. J Clin Endocrinol Metab. 2006;91(6):2317–2326 Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ. 2003;326(7404):1419 Shen F, Liu X, Geng JG, Guo SW. Increased immunoreactivity to SLIT/ROBO1 in ovarian endometriomas: a likely constituent biomarker for recurrence. Am J Pathol. 2009;175(2):479–488 Parker JD, Leondires M, Sinaii N, Premkumar A, Nieman LK, Stratton P. Persistence of dysmenorrhea and nonmenstrual pain after optimal endometriosis surgery may indicate adenomyosis. Fertil Steril. 2006;86(3):711–715 Kissler S, Zangos S, Kohl J, et al. Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol. 2008;137(2):204–209 Berridge MJ, Irvine RF. Inositol trisphosphate, a novel second messenger in cellular signal transduction. Nature. 1984;312(5992):315–321 Matlhagela K, Borsick M, Rajkhowa T, Taub M. Identification of a prostaglandin-responsive element in the Na,K-ATPase beta 1 promoter that is regulated by cAMP and Ca2+. Evidence for an interactive role of cAMP regulatory element-binding protein and Sp1. J Biol Chem. 2005;280(1):334–346 Zhang X, Yao H, Huang X, Lu B, Xu H, Zhou C. Nerve fibres in ovarian endometriotic lesions in women with ovarian endometriosis. Hum Reprod. 2010;25(2):392–397 Nie J, Liu XS, Guo SW. Immunoreactivity of oxytocin receptor (OTR) and transient receptor potential vanilloid type 1 (TRPV1) and its correlation with dysmenorrhea in adenomyosis. Am J Obstet Gynecol. 2010;202(4):346 Bulletti C, DE Ziegler D, Setti PL, Cicinelli E, Polli V, Flamigni C. The patterns of uterine contractility in normal menstruating women: from physiology to pathology. Ann N Y Acad Sci. 2004;1034:64–83 Kitlas A, Oczeretko E, Swiatecka J, Borowska M, Laudanski T. Uterine contraction signals-application of the linear synchronization measures. Eur J Obstet Gynecol Reprod Biol. 2009;144(suppl 1):S61–S64 Green AR, Styles JA, Parrott E, et al. The role of nerve growth factor in the development of adenomyosis in CD-1 mice caused by tamoxifen (Abstract). Toxicol. 2004;194(5):264–265 Chen MC, Lin H, Hsu FN, Huang PH, Lee GS, Wang PS. Involvement of cAMP in nerve growth factor-triggered p35/Cdk5 activation and differentiation in PC12 cells. Am J Physiol Cell Physiol. 2010;299(2):C516–C527 Walsh DA, McWilliams DF, Turley MJ, Dixon MR, Franses RE, Mapp PI, Wilson D. Angiogenesis and nerve growth factor at the osteochondral junction in rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 2010;49(10):1852–1861 Chen JC, Wiley AA, Ho TY, et al. Transient estrogen exposure from birth affects uterine expression of developmental markers in neonatal gilts with lasting consequences in pregnant adults. Reproduction. 2010;139(3):623–630 Tarleton BJ, Braden TD, Wiley AA, Bartol FF. Estrogen-induced disruption of neonatal porcine uterine development alters adult uterine function. Biol Reprod. 2003;68(4):1387–1393 Tarleton BJ, Wiley AA, Bartol FF. Neonatal estradiol exposure alters uterine morphology and endometrial transcriptional activity in prepubertal gilts. Domest Anim Endocrinol. 2001;21(2):111–125 Hayashi K, Carpenter KD, Spencer TE. Neonatal estrogen exposure disrupts uterine development in the postnatal sheep. Endocrinology. 2004;145(7):3247–3257 Cimafranca MA, Davila J, Ekman GC, et al. Acute and chronic effects of oral genistein administration in neonatal mice. Biol Reprod. 2010;83(1):114–121 Weaver IC. Epigenetic effects of glucocorticoids. Semin Fetal Neonatal Med. 2009;14(3):143–150 Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Mao, X., Wang, Y., Carter, A.V. et al. The Retardation of Myometrial Infiltration, Reduction of Uterine Contractility, and Alleviation of Generalized Hyperalgesia in Mice With Induced Adenomyosis by Levo-Tetrahydropalmatine (l-THP) and Andrographolide. Reprod. Sci. 18, 1025–1037 (2011). https://doi.org/10.1177/1933719111404610 Published: Issue date: DOI: https://doi.org/10.1177/1933719111404610

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisadenomyosisdysmenorrhea

MeSH descriptors

Analgesics, Non-Narcotic Berberine Alkaloids Endometriosis Hyperalgesia Uterine Contraction Uterine Diseases Uterine Diseases Analgesics, Non-Narcotic Animals Anti-Inflammatory Agents, Non-Steroidal Anti-Inflammatory Agents, Non-Steroidal Berberine Alkaloids Diterpenes Diterpenes Endometriosis Endometriosis Female Hyperalgesia Hyperalgesia Mice

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-06-12T06:13:51.797165+00:00
pubmed
last seen: 2026-05-13T22:16:48.482574+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine